DermTech Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 2.3yrs |
| Board average tenure | 5.3yrs |
Recent management updates
Recent updates
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%
May 21
We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate
Mar 02Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%
Mar 02Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price
Dec 28Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky
Sep 18Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?
Jun 14Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023
May 10DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%
May 06We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate
Jan 16Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)
Nov 08Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?
Oct 11DermTech grants stock options
Oct 11Diving Into DermTech
Sep 01Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80
Aug 10DermTech: Approaching An All Or Nothing Moment
Jun 13We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate
Jun 04DermTech - Taking A Second Look At The Growth Thesis
Mar 31DermTech: Adoption Headwinds And Earnings Misses
Dec 23Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth
Dec 02CEO
DermTech has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | no data | US$480.83k | no data | |
| Head of Finance | no data | no data | no data | |
| Senior Director of Investor Relations | no data | no data | no data | |
| Chief Compliance Officer | 2.3yrs | no data | no data | |
| Chief Medical Officer | 3.4yrs | no data | no data |
2.3yrs
Average Tenure
Experienced Management: DMTK.Q's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 5.3yrs | US$149.64k | 0.28% $ 0.1 | |
| Independent Director | 2.3yrs | US$136.64k | 0.094% $ 0.03 | |
| Independent Chairman of the Board | 8.3yrs | US$188.64k | 0.35% $ 0.1 | |
| Independent Director | 2.3yrs | US$139.64k | 0.081% $ 0.03 | |
| Independent Director | 5.3yrs | US$156.64k | 0.20% $ 0.07 | |
| Member of Clinical Advisory Board | 7.1yrs | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Independent Director | 3.1yrs | US$134.64k | 0.092% $ 0.03 | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | 5.8yrs | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data |
5.3yrs
Average Tenure
62yo
Average Age
Experienced Board: DMTK.Q's board of directors are considered experienced (5.3 years average tenure).